<DOC>
	<DOCNO>NCT00197834</DOCNO>
	<brief_summary>This prospective , naturalistic , open label study test hypothesis Depakote correlate reduction elevate Cohen-Mansfield Agitation Index ( CMAI ) verbal physical agitation aggression scale 6-week period among patient elevated score scale , positive result achieve few side effect agent . In addition , patient rat respect change Clinical Global Impression ( CGI ) baseline , week 1 , 3 , 6 Neuropsychiatric Inventory ( NPI ) baseline week 6 .</brief_summary>
	<brief_title>Study Depakote Behavioral Psychological Symptoms Dementia</brief_title>
	<detailed_description>This open label , naturalistic study enroll total 20 patient treated Behavioral Psychological Symptoms Dementia ( BPSD ) , newly try Depakote either ER sprinkle formulation . Patients suitable study inclusion score least 4 ( 5 , 5 severe ) least one item ( verbal agitation , physical agitation , aggression ) Cohen-Mansfield Agitation Inventory ( CMAI ) , short form . In study Depakote ER prescribe addition exist pharmacotherapy ; washout co-prescribed psychotropic agent . The study seek enroll equal number patient Depakote vs. concomitant treatment . Study subject recruit multiple assisted living , nurse home hospital site Massachusetts . We anticipate roughly mirror age , gender , demographic distribution large SCU population . This rolling enrollment patient present symptom appropriate treatment . Our estimate base past experience referral rate medication evaluation site . Patients currently atypical antipsychotic residual BPSD consider study , acetylcholinesterase inhibitor . Our logic prescribe , agent desire effect reduce BPSD . Patients take , appropriate remain , conventional antipsychotic exclude study . For enrolled patient obtain baseline psychiatric medical assessment ; result Mini Mental Status Evaluation ( MMSE ) , CMAI , NPI â€“ NH version CGI ; nursing staff patient status report prior begin psychotropic medication . These complete time study enrollment . Patients follow six week , valproic acid level draw week 1,3 , 6 . Nursing staff complete CMAI baseline week 1 , 3 , 6 . Physicians score patient CGI baseline , week 1 , 3 , 6 , Clinical Raters complete NPI baseline week 6 .</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Diagnostic Statistical Manual Mental DisordersFourth Edition ( DSMIV ) dementia diagnosis Age &gt; = 60 year MMSE &gt; 7 Clinical evidence behavioral disturbance evidence nursing staff report mean score &gt; 4 least one CMAI item May remain coprescribed psychotropic agent ( e.g. , antidepressant , atypical antipsychotic , acetylcholinesterase inhibitor ) Patients schizophrenia , bipolar disorder , seizure disorder comorbid dementia Patients delirium , poorly control medical illness MMSE &gt; 24 Lack significant behavioral disturbance Low platelet count Liver function test ( LFTs ) &gt; 2x normal Currently Depakote formulation prior unsuccessful trial Depakote Currently lamotrigine ( Lamictal ) Not currently intend initiate treatment acetylcholinesterase inhibitor memantine course study .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Depakote</keyword>
	<keyword>Agitation</keyword>
	<keyword>Dementia</keyword>
	<keyword>Atypical antipsychotic</keyword>
	<keyword>Behavioral Symptoms</keyword>
	<keyword>Psychiatric Symptoms</keyword>
	<keyword>Psychological Symptoms</keyword>
	<keyword>Geriatric</keyword>
	<keyword>Behavioral Psychological Symptoms</keyword>
</DOC>